The Good The Bad and The Ugly, What Europe Can Learn from the U.S. and Canadian Cannabis Industries

November 9, 2020
Michael Sassano
Europe, Op-Ed
0 Comments

Europe has a lot to learn from the U.S. and Canada as it transforms: the good, the bad, and the ugly. Cannabis not only has proven medical benefits but financial benefits to both consumers and countries that benefit from greater…

It’s Far’s Far Too Soon To Think About Celebrating The Legitimacy of Cannabis Because The War On Pot Is Still Raging

By Doug Poretz The kneejerk reaction to a discussion about the cannabis industry is to be jubilant. After all, we see high growth among a wide segment of players from growers to lighting companies, a virtual tsunami of all sorts of…

5 Big Predictions for Cannabis This Year

Big pharma, microdosing and inter-state commerce are among some trends to watch. Opinions expressed by Green Entrepreneur contributors are their own. Just a few months into 2019, and it’s proving to be another wild year for the cannabis industry. More…

Big Pharma is Coming for the Cannabis Industry

January 5, 2019
John Taenzler
Medical Marijuana, Science and Technology
0 Comments

In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or…

Former Big Pharma Exec Makes the Switch From OxyContin to Marijuana

John Stewart used to run the pharmaceutical company behind the narcotic painkiller OxyContin. Now he is banking on medical marijuana. Mr Stewart does not know which is more controversial these days, OxyContin or pot. He guesses the average person would…

DEA and Big Pharma: The Tangled Web of the Opioid Crisis

By Ralph Morgan Cannabis Industry leaders and activists are seemingly the only two groups with a sense of urgency to find a reasonable alternative pain remedy to replace synthetic opioids. Pharmaceuticals are responsible for a death every 19 minutes. Big…

Big Pharma Seeks to Capitalize on Pain-Reducing Compound Derived From Cannabis

The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma -- not to…

Big Pharma Expresses Interest in Medical Cannabis

At least once a week, Steve McDonald drives from his home in Irvine to an industrial stretch of Santa Ana filled with auto shops and home-improvement wholesalers. Inside a beige storefront, McDonald consults with young budtenders about the jars of…

One Thing Is Clear: Big Pharma Does Not Want Legalization

There's a body of research showing that painkiller abuse and overdose are lower in states with medical marijuana laws. These studies have generally assumed that when medical marijuana is available, pain patients are increasingly choosing pot over powerful and deadly prescription…